Do specific predictors and interventions improve adherence to anti-hypertensive therapy in hypertensive patients?
Relatively small interventions, such as cost reduction and personalized education, can substantially improve adherence to antihypertensive therapy.
Low adherence to antihypertensive therapy is one of the main modifiable risk factors for several other secondary pathologies. Therefore, we aimed to evaluate the predictors that most interfere in the adherence process. This is a systematic review with meta-analysis that followed the Cochrane recommendations, the search for studies occurred between January and February 2020 using the MeSH: "Hypertensive", "Medication Adherence", "World Population" and "Risk Factors". After applying the filters and criteria 31 studies were selected. The review included studies with intended perspectives and the main predictors were: interventions, satisfaction, cost reduction, the factors were also found: diagnostic impact, medical inertia and execution of the prescribed regimes. The research exposed that more work is needed on health promotion by age group and hypertension (SAH) can be detected and controlled early, readjust high costs, ensure well-being and satisfaction in therapy so that the patient can feel comfortable. Personalized recommendations and constructive comments can drive this process, it is necessary to develop actions aimed at greater compliance by reducing the impact of these diseases and promoting greater control Compliance has always been complex by nature. However, relatively small interventions can substantially improve it. Keywords: Hypertensive; Medication Adherence; World Population; e Risk Factors.
Neto et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: